Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial
Toby J L Humphrey, Wendi Qian, Michael Chen-Xu, Francis Dowling et autres